ABSTRACT Early identification of patients with treatment‐responsive rapidly progressive dementia (RPD) is important as early treatment improves outcomes. The STAM 3 P score identifies treatment‐responsive RPD using “high risk” presenting features. We optimized performance by adding a time component (i.e., dementia within 3 months) and validated the modified “STAM3 m P score” in two independent cohorts ( n = 302). A STAM3 m P score ≥ 1 identified 96% of patients with treatment‐responsive RPD; ≥ 3 features were highly specific (98%). These data suggest that ≥ 1 STAM3 m P features effectively identifies treatment‐responsive RPD and may be used to prioritize investigations, whereas ≥ 3 STAM3 m P features are highly specific and may inform early treatment decisions.
Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia
Neurology | May 15, 2026 | Volume: 106 | Issue: 11 | Pages: No page available
Autoimmune Encephalitis Is the Most Common Treatment-Responsive Cause of Rapidly Progressive Dementia; a Large Dutch Prospective Cohort Study. (PL4.002)
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available